Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Graham Andrew Colditz, M.D., Dr.P.H., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Graham Colditz and Stuart Schnitt.
Connection Strength

2.220
  1. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012 May; 129(5):e1192-8.
    View in: PubMed
    Score: 0.128
  2. Adolescent intakes of alcohol and folate and risk of proliferative benign breast disease. J Clin Oncol. 2011 Sep 20; 29(27_suppl):169.
    View in: PubMed
    Score: 0.123
  3. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat. 2011 Aug; 129(1):175-84.
    View in: PubMed
    Score: 0.119
  4. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011 Jul; 128(1):243-50.
    View in: PubMed
    Score: 0.117
  5. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010 Jul; 21(7):1033-46.
    View in: PubMed
    Score: 0.111
  6. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007 Jan 15; 109(2):180-7.
    View in: PubMed
    Score: 0.089
  7. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006 Sep 15; 107(6):1240-7.
    View in: PubMed
    Score: 0.087
  8. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2889-97.
    View in: PubMed
    Score: 0.082
  9. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2005; 7(4):R555-62.
    View in: PubMed
    Score: 0.079
  10. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005 May 01; 103(9):1778-84.
    View in: PubMed
    Score: 0.079
  11. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer. 2004 Oct 01; 101(7):1490-500.
    View in: PubMed
    Score: 0.076
  12. A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1106-13.
    View in: PubMed
    Score: 0.075
  13. Adolescent diet and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev. 2003 Nov; 12(11 Pt 1):1159-67.
    View in: PubMed
    Score: 0.071
  14. Alcohol consumption and incidence of benign breast disease. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1369-74.
    View in: PubMed
    Score: 0.067
  15. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002 Jul 20; 100(3):375-8.
    View in: PubMed
    Score: 0.065
  16. Pathologic features of breast cancers in women with previous benign breast disease. Am J Clin Pathol. 2001 Mar; 115(3):362-9.
    View in: PubMed
    Score: 0.059
  17. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer. 2000 Nov 15; 89(10):2046-52.
    View in: PubMed
    Score: 0.058
  18. Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2358-2368.
    View in: PubMed
    Score: 0.057
  19. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med. 1999 Feb 11; 340(6):430-6.
    View in: PubMed
    Score: 0.051
  20. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997 May; 6(5):297-301.
    View in: PubMed
    Score: 0.045
  21. Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies. Cancer. 2016 Feb 15; 122(4):515-20.
    View in: PubMed
    Score: 0.041
  22. Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers. Br J Cancer. 2015 Sep 29; 113(7):1104-13.
    View in: PubMed
    Score: 0.041
  23. Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease. Cancer Causes Control. 2015 Jan; 26(1):79-90.
    View in: PubMed
    Score: 0.038
  24. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013 Oct 16; 105(20):1571-8.
    View in: PubMed
    Score: 0.035
  25. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 2013 May; 139(1):277-85.
    View in: PubMed
    Score: 0.034
  26. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat. 2012 Jul; 134(2):783-91.
    View in: PubMed
    Score: 0.032
  27. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992 Feb 19; 267(7):941-4.
    View in: PubMed
    Score: 0.032
  28. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(1):159-67.
    View in: PubMed
    Score: 0.031
  29. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 03; 103(15):1179-89.
    View in: PubMed
    Score: 0.030
  30. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011 Sep; 22(9):1297-305.
    View in: PubMed
    Score: 0.030
  31. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011 Nov; 130(2):657-62.
    View in: PubMed
    Score: 0.030
  32. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011 Apr 01; 17(7):1867-74.
    View in: PubMed
    Score: 0.030
  33. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):185-92.
    View in: PubMed
    Score: 0.029
  34. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010; 12(4):R61.
    View in: PubMed
    Score: 0.028
  35. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010 Jan 01; 126(1):180-90.
    View in: PubMed
    Score: 0.027
  36. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):438-41.
    View in: PubMed
    Score: 0.027
  37. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009 Apr 01; 115(7):1404-11.
    View in: PubMed
    Score: 0.026
  38. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4):R67.
    View in: PubMed
    Score: 0.025
  39. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):873-9.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.